Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 20, 2023

SELL
N/A
-1,063 Reduced 3.31%
31,061 $48,000
Q4 2022

Jan 12, 2023

SELL
N/A
-46,255 Reduced 59.01%
32,124 $20,000
Q3 2022

Nov 14, 2022

SELL
$1.29 - $2.52 $4,167 - $8,142
-3,231 Reduced 3.96%
78,379 $104,000
Q2 2022

Jul 19, 2022

SELL
$2.22 - $6.7 $6,422 - $19,383
-2,893 Reduced 3.42%
81,610 $181,000
Q1 2022

Apr 26, 2022

SELL
$4.18 - $13.39 $5,914 - $18,946
-1,415 Reduced 1.65%
84,503 $523,000
Q4 2021

Feb 14, 2022

SELL
$11.35 - $97.17 $39,736 - $340,192
-3,501 Reduced 3.92%
85,918 $1.08 Million
Q3 2021

Nov 12, 2021

BUY
$52.0 - $120.21 $400,036 - $924,775
7,693 Added 9.41%
89,419 $8.2 Million
Q2 2021

Aug 13, 2021

BUY
$31.88 - $58.66 $838,985 - $1.54 Million
26,317 Added 47.5%
81,726 $4.33 Million
Q1 2021

May 17, 2021

BUY
$28.6 - $49.21 $1.58 Million - $2.73 Million
55,409 New
55,409 $2 Million

Others Institutions Holding CRTX

About Cortexyme, Inc.


  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track Hennion & Walsh Asset Management, Inc. Portfolio

Follow Hennion & Walsh Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.